BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22767069)

  • 21. Apoptin enhances the oncolytic properties of Newcastle disease virus.
    Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
    Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.
    Yuan L; Zhao H; Zhang L; Liu X
    Tumour Biol; 2013 Oct; 34(5):3027-34. PubMed ID: 23907578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene.
    Pietersen AM; van der Eb MM; Rademaker HJ; van den Wollenberg DJ; Rabelink MJ; Kuppen PJ; van Dierendonck JH; van Ormondt H; Masman D; van de Velde CJ; van der Eb AJ; Hoeben RC; Noteborn MH
    Gene Ther; 1999 May; 6(5):882-92. PubMed ID: 10505114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient production of an engineered apoptin from chicken anemia virus in a recombinant E. coli for tumor therapeutic applications.
    Lee MS; Sun FC; Huang CH; Lien YY; Feng SH; Lai GH; Lee MS; Chao J; Chen HJ; Tzen JT; Cheng HY
    BMC Biotechnol; 2012 Jun; 12():27. PubMed ID: 22672291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTD4-apoptin induces Bcl-2-insensitive apoptosis in human cervical carcinoma in vitro and in vivo.
    Liu XW; Yuan P; Tian J; Li LJ; Wang Y; Huang SC; Liu L; Backendorf C; Noteborn MH; Sun J
    Anticancer Drugs; 2016 Nov; 27(10):979-87. PubMed ID: 27548349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
    Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-targeted delivery of TAT-Apoptin fusion gene using Escherichia coli Nissle 1917 to colorectal cancer.
    Zhou S; Zhang M; Wang J
    Med Hypotheses; 2011 Apr; 76(4):533-4. PubMed ID: 21256681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of therapeutic proteins as secretable TAT fusion products.
    Flinterman M; Farzaneh F; Habib N; Malik F; Gäken J; Tavassoli M
    Mol Ther; 2009 Feb; 17(2):334-42. PubMed ID: 19050698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.
    Zhang KJ; Qian J; Wang SB; Yang Y
    J Biomed Sci; 2012 Feb; 19(1):20. PubMed ID: 22321574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
    Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of CDK1 in apoptin-induced apoptosis in hepatocellular carcinoma cells.
    Zhao J; Han SX; Ma JL; Ying X; Liu P; Li J; Wang L; Zhang Y; Ma J; Zhang L; Zhu Q
    Oncol Rep; 2013 Jul; 30(1):253-9. PubMed ID: 23619525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptin sensitizes radiation-induced cell death via classic mitochondrial, caspase and p53-dependent signaling in HepG2 cells.
    Han SX; Zhu Q; Ma JL; Lv Y; Zhao J; Huang C; Jia X; Ou W; Guo HT
    Mol Med Rep; 2011; 4(1):59-63. PubMed ID: 21461564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
    GAO Y; ZHANG W; ZHAO L; WANG XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):363-7. PubMed ID: 19497203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
    Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
    Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.